CD8A and neoplasm: Histological and immunohistochemical analyses showed increases in CD8+ and CD4+ tumour-infiltrating lymphocytes (TILs) in most paired tumours after CAN-3110 treatment (Extended Data Fig. 6c and Supplementary Table 2b).